“Tapinarof Cream 1% Once Daily: Disease Control Off Treatment and Minimal Disease Activity Through End of Remittive Period in a 1-year Trial” (2023) SKIN The Journal of Cutaneous Medicine, 7(2), p. s125. doi:10.25251/skin.7.supp.125.